Search for Clinical Trial Results
Primary Central Nervous System Lymphoma - 27 Studies Found
Status | Study |
Recruiting |
Study Name: Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma Condition: Recurrent or Refractory Primary CNS Lymphoma Date: 2009-07-20 Interventions: Drug: temsirolimus Weekly infusion of 25mg Temsirolimus (first 3 patients) or 75mg Temsirolimus (all oth |
Recruiting |
Study Name: Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma Condition: Lymphoma Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma Condition: Lymphoma Date: 2000-09-11 Interventions:
|
Withdrawn |
Study Name: Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Condition: Lymphoma Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma Condition: Lymphoma Date: 2003-12-10 Interventions:
|
NOT_YET_RECRUITING |
Study Name: Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study Condition: Date: 2024-05-19 Interventions: 1.8 Gy of 4-6 MV X-ray to a total dose of 23.4 Gy (13 fractions) will be delivered. |
RECRUITING |
Study Name: Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas Condition: Primary Central Nervous System Lymphoma Date: 2024-05-19 Interventions: Participants will receive 900 mg/m^2 via IV infusion over 10 minutes every 3 weeks x 4-8 induction cycles (21 days per cycle) as part of the indu |